TG Therapeutics Inc (TGTX)
Net profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 23,383 | -14,364 | 95,686 | 41,197 | 12,672 | -25,906 | -175,654 | -168,554 | -198,335 | -238,679 | -288,498 | -326,485 | -348,100 | -342,980 | -344,506 | -318,893 | -279,381 | -230,734 | -205,501 | -188,830 |
| Revenue (ttm) | US$ in thousands | 329,004 | 262,359 | 340,582 | 280,254 | 222,343 | 180,883 | 18,875 | 6,331 | 2,784 | 5,025 | 6,961 | 7,912 | 6,689 | 4,406 | 2,414 | 907 | 152 | 152 | 152 | 152 |
| Net profit margin | 7.11% | -5.47% | 28.09% | 14.70% | 5.70% | -14.32% | -930.62% | -2,662.36% | -7,124.10% | -4,749.83% | -4,144.49% | -4,126.45% | -5,204.07% | -7,784.38% | -14,271.17% | -35,159.10% | -183,803.29% | -151,798.68% | -135,198.03% | -124,230.26% |
December 31, 2024 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $23,383K ÷ $329,004K
= 7.11%
Over the period from March 31, 2020, to December 31, 2024, TG Therapeutics Inc experienced highly negative net profit margins, which improved gradually over time. The company reported significant losses early on, with net profit margins ranging from around -124,230% to -183,803% in the first few quarters. However, there was a visible turnaround starting from March 31, 2021, with the net profit margin improving to -35,159% and progressing consistently in subsequent periods.
By the end of December 31, 2023, the net profit margin had turned positive, standing at 5.70%, signifying a shift from losses to profitability. This positive momentum continued into 2024, where the company achieved net profit margins of 14.70% and 28.09% as of March 31 and June 30, respectively. However, there was a slight decline in profitability by September 30, 2024, with a net profit margin of -5.47%, before recovering to 7.11% by December 31, 2024.
Overall, the net profit margin trend for TG Therapeutics Inc reflects a significant improvement in financial performance, moving from deep losses to profitability over the analyzed period, demonstrating the company's efforts in enhancing operational efficiency and financial health.
Peer comparison
Dec 31, 2024